Sandoval et al. investigated the molecular mechanisms of ezetimibe on postprandial hyperlipidemia in MetS using CD36 knockout mice and established a model for evaluating postprandial hypertriglyceridemia in a MetS environment [33]. The gene discussed is CD36; the disease is metabolic syndrome.